The global gene editing market is expected to grow at a CAGR of more than 14% during the forecast period. The market growth is attributed to the increasing prevalence of cancer and other genetic disorders, increasing demand for precision medicines, and a significant rise in the R&D expenditure on the healthcare industry. In addition, an increase in private and public sector funding, growth of biotechnology and pharmaceutical industries, and rapid advancements in sequencing and Genome Editing technologies drive the growth of the market.